Literature DB >> 11090062

VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis.

K Hamada1, Y Oike, N Takakura, Y Ito, L Jussila, D J Dumont, K Alitalo, T Suda.   

Abstract

Signaling by vascular endothelial growth factors (VEGFs) through VEGF receptors (VEGFRs) plays important roles in vascular development and hematopoiesis. The authors analyzed the function of VEGF-C signaling through both VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis using a coculture of para-aortic splanchnopleural mesoderm (P-Sp) explants from mouse embryos with stromal cells (OP9). Vasculogenesis and angiogenesis were evaluated by the extent of vascular bed and network formation, respectively. Addition of VEGF-C to the P-Sp culture enhanced vascular bed formation and suppressed definitive hematopoiesis. Both vascular bed and network formations were completely suppressed by addition of soluble VEGFR-1-Fc competitor protein. Formation of vascular beds but not networks could be rescued by VEGF-C in the presence of the competitor, while both were rescued by VEGF-A. VEGFR-3-deficient embryos show the abnormal vasculature and severe anemia. Consistent with these in vivo findings, vascular bed formation in the P-Sp from the VEGFR-3-deficient embryos was enhanced to that in wild-type or heterozygous embryos, and hematopoiesis was severely suppressed. When VEGFR-3-Fc chimeric protein was added to trap endogenous VEGF-C in the P-Sp culture of the VEGFR-3-deficient embryos, vascular bed formation was suppressed and hematopoiesis was partially rescued. These results demonstrate that because VEGF-C signaling through VEGFR-2 works synergistically with VEGF-A, the binding of VEGF-C to VEGFR-3 consequently regulates VEGFR-2 signaling. In VEGFR-3-deficient embryos, an excess of VEGF-C signals through VEGFR-2 induced the disturbance of vasculogenesis and hematopoiesis during embryogenesis. This indicates that elaborated control through VEGFR-3 signaling is critical in vasculoangiogenesis and hematopoiesis. (Blood. 2000;96:3793-3800)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11090062

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  40 in total

Review 1.  Angiogenesis in hematologic malignancies and its clinical implications.

Authors:  Renchi Yang; Zhong Chao Han
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

2.  Selective role of a distinct tyrosine residue on Tie2 in heart development and early hematopoiesis.

Authors:  Kazunobu Tachibana; Nina Jones; Daniel J Dumont; Mira C Puri; Alan Bernstein
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

Review 3.  Developmental and pathological lymphangiogenesis: from models to human disease.

Authors:  Hélène Maby-El Hajjami; Tatiana V Petrova
Journal:  Histochem Cell Biol       Date:  2008-10-23       Impact factor: 4.304

4.  Vascular endothelial growth factor-C ameliorates renal interstitial fibrosis through lymphangiogenesis in mouse unilateral ureteral obstruction.

Authors:  Shoko Hasegawa; Toshiaki Nakano; Kumiko Torisu; Akihiro Tsuchimoto; Masahiro Eriguchi; Naoki Haruyama; Kosuke Masutani; Kazuhiko Tsuruya; Takanari Kitazono
Journal:  Lab Invest       Date:  2017-10-30       Impact factor: 5.662

5.  Nucleoside/nucleotide reverse transcriptase inhibitors attenuate angiogenesis and lymphangiogenesis by impairing receptor tyrosine kinases signalling in endothelial cells.

Authors:  Lin Song; Sha Ding; Zhen Ge; Xiaolong Zhu; Cong Qiu; Yuewen Wang; Enyin Lai; Weijun Yang; Yi Sun; Samson A Chow; Luyang Yu
Journal:  Br J Pharmacol       Date:  2017-10-25       Impact factor: 8.739

6.  Vegf signaling promotes vascular endothelial differentiation by modulating etv2 expression.

Authors:  Satish Casie Chetty; Megan S Rost; Jacob Ryan Enriquez; Jennifer A Schumacher; Kristina Baltrunaite; Andrea Rossi; Didier Y R Stainier; Saulius Sumanas
Journal:  Dev Biol       Date:  2017-03-07       Impact factor: 3.582

7.  Regulation of Vegf signaling by natural and synthetic ligands.

Authors:  Andrea Rossi; Sebastien Gauvrit; Michele Marass; Luyuan Pan; Cecilia B Moens; Didier Y R Stainier
Journal:  Blood       Date:  2016-08-24       Impact factor: 22.113

Review 8.  Lymphatic Vessel Network Structure and Physiology.

Authors:  Jerome W Breslin; Ying Yang; Joshua P Scallan; Richard S Sweat; Shaquria P Adderley; Walter L Murfee
Journal:  Compr Physiol       Date:  2018-12-13       Impact factor: 9.090

9.  Neostatin-7 regulates bFGF-induced corneal lymphangiogenesis.

Authors:  Takashi Kojima; Dimitri T Azar; Jin-Hong Chang
Journal:  FEBS Lett       Date:  2008-06-18       Impact factor: 4.124

10.  IL-12 suppresses vascular endothelial growth factor receptor 3 expression on tumor vessels by two distinct IFN-gamma-dependent mechanisms.

Authors:  Elizabeth W Sorensen; Scott A Gerber; John G Frelinger; Edith M Lord
Journal:  J Immunol       Date:  2010-01-08       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.